Vinpocetine
Useful mainly for cerebrovascular insufficiency in countries where it is a prescription drug; weak as a general nootropic.
Quick decision guide
May help most
cerebrovascular insufficiency in countries where it is a prescription drug; weak as a general nootropic
Common dosing range
10–40 mg/day, divided; research used 30–60 mg/day
When to expect effects
Weeks for cognitive endpoints
Watch out for
FDA warns against use in pregnancy; antiplatelet (bleeding) activity
What is it
Vinpocetine is a semi-synthetic compound derived from vincamine, an alkaloid extracted from the lesser periwinkle plant (Vinca minor). It is approved as a prescription medication for cerebrovascular conditions in several countries including Hungary, Russia, and Japan, and is marketed as a dietary supplement in the United States for cognitive support.
Is it worth it for you?
Use this as a quick fit check, not a diagnosis.
Worth considering if…
Probably skip if…
Evidence at a glance
| Goal | Effect | Best fit | Time |
|---|---|---|---|
cerebrovascular insufficiency Limited Evidence | Unclear; possible modest symptom improvement | adults with cerebrovascular insufficiency, under medical care | Weeks |
post-stroke cognitive impairment Limited Evidence | Unclear; small if any | patients recovering from ischemic stroke, under medical care | Weeks |
general cognitive enhancement Mixed Evidence | No reliable benefit | none clearly identified | Weeks |
cerebrovascular insufficiency
- Effect
- Unclear; possible modest symptom improvement
- Best fit
- adults with cerebrovascular insufficiency, under medical care
- Time
- Weeks
post-stroke cognitive impairment
- Effect
- Unclear; small if any
- Best fit
- patients recovering from ischemic stroke, under medical care
- Time
- Weeks
general cognitive enhancement
- Effect
- No reliable benefit
- Best fit
- none clearly identified
- Time
- Weeks
Evidence for 3 uses
AI-assisted evidence assessment — talk to your doctor before relying on any single supplement.
cerebrovascular insufficiency
Disease adjunctAs a PDE1 inhibitor, vinpocetine increases cerebral blood flow and is a prescription treatment for cerebrovascular conditions in several countries. Clinical trials are older, heterogeneous, and of limited quality, so confidence is low despite its regulated use abroad. It is not FDA-approved for any indication in the US.
Bottom line: Vinpocetine may modestly help cerebrovascular symptoms, but the trial evidence is limited.
post-stroke cognitive impairment
Disease adjunctVinpocetine has been studied as an adjunct for post-stroke cognitive symptoms, with some older trials suggesting benefit. The evidence base is small, dated, and inconsistent, and a Cochrane review found insufficient evidence to support routine use. Confidence is low.
Bottom line: Evidence for vinpocetine in post-stroke cognition is limited and inconclusive.
Evidence is mixed
Some older trials report benefit, but systematic reviews find the evidence insufficient to draw conclusions.
general cognitive enhancement
Supplement benefitDespite marketing as a nootropic, evidence that vinpocetine improves cognition in healthy adults or age-related memory decline is weak and conflicting. No consistent benefit has been demonstrated for general cognitive enhancement. Given the bleeding risk and pregnancy warning, the risk-benefit balance is unfavorable for casual use.
Bottom line: Vinpocetine is not a reliable general cognitive enhancer.
Evidence is mixed
Marketed for memory and focus, but trials in healthy adults and age-related decline are inconsistent and largely negative.
How it works
How to take it
What to track
2 commercial forms
Compare the main delivery options and what they’re best suited for.
Vinpocetine tablets/capsules
Standard oral supplement form. Take with food to enhance bioavailability.
Standard form; absorption roughly doubled when taken with food.
Sustained-release vinpocetine
Available in some markets; provides extended drug levels with fewer dose-related peaks.
Smoother blood levels over time; may improve tolerability.
Safety
Know the common side effects, key cautions, and who should avoid it.
Common side effects
Serious risks
increased bleeding risk from antiplatelet activity
Who should avoid it
- pregnant and breastfeeding women
- people on anticoagulants or antiplatelet drugs
- those with bleeding disorders
- anyone within 2 weeks of surgery
Pregnancy & breastfeeding
Avoid in pregnancy; the FDA has warned of reproductive toxicity risk.
Interactions
additive bleeding risk from antiplatelet activity
additive bleeding risk
may modestly lower blood pressure further
Choosing a product
What to look for on the label — and what to be skeptical of.
Look for…
Be skeptical of…
Frequently asked questions
Is vinpocetine FDA approved?⌄
No. Vinpocetine is approved as a prescription medication in Hungary, Russia, Japan, and other countries but not in the United States. It is sold in the US as a dietary supplement, though the FDA has expressed concerns about its safety in this context.
Does vinpocetine improve memory?⌄
Evidence is mixed. Some studies suggest benefits for memory and cognition, particularly in people with cerebrovascular insufficiency. Effects in healthy individuals are less clear.
Is vinpocetine safe during pregnancy?⌄
No. The FDA issued a 2019 warning that vinpocetine may cause harm during pregnancy and should be avoided by pregnant women and those who could become pregnant.
Can vinpocetine cause bleeding?⌄
Yes. Vinpocetine has antiplatelet effects that can increase bleeding risk, particularly when combined with blood thinners. Discontinue 2 weeks before surgery.
How long until I see effects?⌄
Cognitive benefits typically require several weeks of consistent use to assess. Cerebral blood flow effects may occur within hours of a dose.
References by claim
Track Vinpocetine with Pilora
Set up dose reminders, check interactions, and join the community in the Pilora iPhone app.
Coming to App StoreDisclaimer: These statements have not been evaluated by the FDA. This page is educational, not a substitute for personalized medical advice. Evidence grades are AI-assisted assessments — talk to your doctor before starting any new supplement, especially if you’re pregnant, breastfeeding, on medications, or managing a chronic condition.